RNA Stock 12 Month Analyst Forecast
Eps Overview
Consensus Rating
Consensus Price Target
Highest Price Target
$96.00
614.82% Upside
Mean Price Target
$67.78
404.71% Upside
Lowest Price Target
$25.00
86.15% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On Mar 11, 2026
Actual EPS vs Estimated EPS
RNA Earnings Per Share (EPS) History
According to financial reports, RNA (NYSE: RNA) reported an actual EPS of $-1.7 for the quarter ending on Mar 02, 2026, compared to an estimated $-1.24, resulting in a 37.10% surprise. In the prior quarter (Feb 26, 2026), RNA recorded an actual EPS of $-0.61 with a -50.81% surprise. See RNA's full earnings history.
Earnings History
EPS Surprise Factor Analysis
RNA has experienced notable EPS surprises, with the latest quarter ending Mar 02, 2026 showing a 37.10% beat. Previously, the quarter ending Feb 26, 2026 recorded a -50.81% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Mar 02, 2026 | -1.7 | -1.24 | +37.10% |
| Feb 26, 2026 | -0.61 | -1.24 | -50.81% |
| Nov 10, 2025 | -1.27 | -1.05 | +20.95% |
| Aug 07, 2025 | -1.21 | -0.95 | +27.37% |
| May 08, 2025 | -0.9 | -0.88 | +2.27% |
| Feb 27, 2025 | -0.8 | -0.76 | +5.26% |

